| 英文别名 |
(S)-2-((Methoxycarbonyl)amino)-3,3-dimethylbutanoic acid;Methylcarbonyl-L-tert-Leucine;MOC-L-tert. Leucin;N-Methylcarbonyl-L-tert-Leucine;Moc-L-Tert-Leucine;Methylcarbonyl-L-t-leucine;N-Methoxycarbonyl-L-tert-leucine;Methoxycarbonyl-L-Tert-Leucine;(S)-2-(Methoxycarbonylamino)-3,3-dimethylbutanoic acid;(S)-2-Methoxycarbonylamino-3,3-dimethyl-butyric acid;Boc-Glu(OMe)-OH;L-Valine,N-(methoxycarbonyl)-3-methyl-;N-(Methoxycarbonyl)-;N-(Methoxycarbonyl)-L-tert-leucine;(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoic acid;(2S)-2-[(Methoxycarbonyl)amino]-3,3-dimethylbutanoic acid;N-Methoxycarbonyl-3-methyl-L-valine;(2S)-2-Acetamido-3,3-dimethylbutanoic acid;N-α-Acetyl-L-tert-leucine;N-Acyl-tert-Leucine;(S)-2-Methoxycarbonylamino-3,3-dimethylbutyric acid;Moc-L-tert-lecine;MOC-L-tert.Leucine;N-Moc-L-tert-Leucine;Atazanavir related coMpound A;N-Methoxycarbonyl-tert-leucine;Methyl Carbonyl L-tert Leucine;(S)-N-(METHOXYCARBONYL)-TERT-LEUCINE;L-Valine, N-(methoxycarbonyl)-3-methyl-;0L7G8ZHR2P;N-(Methoxycarbonyl)-3-methyl-L-valine;(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbut;methoxycarbonyl-t-leucine;BCP04718;HY-59135;N-(methoxycarbonyl)-(L)-tert-leucine;MFCD07778455;NWPRXAIYBULIEI-RXMQYKEDSA-N;(S)-2-((Methoxycarbonyl)amino)-3,3-dimethylbutanoicacid;Z756468680;DTXSID80460466;162537-11-3;EN300-6347568;ATAZANAVIR SULFATE IMPURITY K [EP IMPURITY];Q-102796;PD196036;N-methoxycarbonyl-(L)-tert-leucine;Atazanavir impurity K;CS-B0635;AC-23469;(2S)-2-((Methoxycarbonyl)amino)-3,3-dimethylbutanoic acid;NS00077750;AS-16159;AKOS010384614;UNII-0L7G8ZHR2P;SCHEMBL6418;DA-75456;DB-109677;302555-22-2 |